Stock analysis · Bull Rankings model

ITRI analysis

Itron, Inc.Scientific & Technical Instruments. Scored on the same transparent model behind the daily rankings.

ITRI
Itron, Inc. · Scientific & Technical Instruments
FCF$385mC
Rev-5.7%D
D/E0.98C
P/E16.7xA-
PEG0.85B+
58.5Score
$99.87$4.4B
1Y Target$129.60Analyst consensus · 10 analysts
5Y Target$163.62Compound horizon
10Y Target$209.83Long-dated conviction
FCF$385mTTM
C
FCF $385m — modest; watch for margin expansion
Rev-5.7%TTM YoY
D
Revenue -5.7% — meaningful contraction
D/E0.98
C
D/E 0.98 — more levered than most Technology peers (≈90th pctile)
P/E16.7x
A-
P/E 16.7 — cheaper than most Technology peers (≈25th pctile)
PEG0.85
B+
PEG 0.85 — near fair value, classic Lynch benchmark (1.0)

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 58.5
Quality65.0
Growth38.9
Value79.1
Why this score
  • Buying back stock
Entry · Margin of safety
52-week rangeMid-range
30% off the 12-month high
vs DCF fair value11% belowest. fair value ~$112
What the price assumes: free cash flow compounding at ~2% a year for the next decade — vs the ~7% a year our model projects from current growth and analyst estimates.
Quality signals · context only
Gross profitability23% · Bgross profit ÷ total assets (Novy-Marx)
ROIC7.5% · C+return on invested capital — not score-weighted

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Scientific & Technical Instruments · market cap $4.4b. Down 30% from 52-week high of $142.00 — deep drawdown territory. Revenue -6% — in contraction; any catalyst that reverses this triggers re-rating. PEG 0.85 — paying under fair value for the growth rate. 10 sell-side analysts rate this a Buy with a mean 1-yr target of $129.60 (implying +30% upside).
Moat
ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 141% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Revenue contracting -6% — the operational turn is not yet visible in the top line.
Horizon
1-3 yr $129.60 (10-analyst consensus) — multiple re-rating thesis requires a catalyst. 5 yr $163.62 at ~10% CAGR — dividend + buyback compounding. 10 yr $209.83 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

ITRI vs the Top Picks average

PillarITRIBook avgDiff
Quality0.650.84-0.19
Growth0.390.84-0.45
Value0.790.78in line

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
+2.3 over 47 daily scores
From 56.2 (Jun 22) → 58.5 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Analyst estimate revisions

30-day change+4.5%
90-day change+3.7%
Forward EPS estimate$6.85

Over the last 90 days, what analysts expect ITRI to earn is drifting higher (+3.7%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
20
Position size
$1,997
4.0% of portfolio
Stop price
$74.90
25% below $99.87
$ at risk if stopped
$499.35
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Itron, Inc. (ITRI): score, valuation & FAQ

Itron, Inc. (ITRI) is a Scientific & Technical Instruments company that scores 58.5 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are P/E (A-) and PEG (B+), while Rev (D) rate weaker. On valuation, ITRI sits about 11% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly 2% annual free-cash-flow growth over the next decade.

Is ITRI a good stock to buy?

Bull Rankings scores ITRI 58.5 out of 100 on its quality-growth model, which is a middling reading. That is driven by P/E (A-) and PEG (B+). A score is a quantitative screen of Itron, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does ITRI score 58.5 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). ITRI earns its highest marks on P/E (A-) and PEG (B+), and is held back by Rev (D). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is ITRI overvalued or undervalued?

Based on $99.87, ITRI sits about 11% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly 2% annual free-cash-flow growth over the next decade. It trades at a 16.7x P/E (graded A-). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in ITRI?

Revenue contracting -6% — the operational turn is not yet visible in the top line.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Test & Measurement stocks by score

All Technology rankings →

Analyze another ticker →